Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00688168 · ClinicalTrials.gov registry record
Inflammatory Cytokines in Symptom Production in Multiple Myeloma
A clinical trial of Multiple Myeloma, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 491
- Enrollment target
- 1
- Study location
NCT00688168: Completed study of Multiple Myeloma, sponsored by M.D. Anderson Cancer Center.
NCT00688168 is a study of Multiple Myeloma that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 491 participants, below the 546-participant average among 438 other Multiple Myeloma trials with a reported enrollment target (10% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00688168, a study of Multiple Myeloma, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 491 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this research study is to learn about the pain and/or other symptoms that patients may experience either while you are being monitored by your doctor before a decision is made to start you on treatment for your MM, or during and after treatment for MM, and how these symptoms may affect therapy. A second goal is to learn how differences in genes may affect the symptom burden from cancer and cancer therapy.
Conditions Studied
Interventions
- BEHAVIORAL Questionnaire
- BEHAVIORAL Neurocognitive Testing
- BEHAVIORAL Neurosensory Testing
Study Locations (1)
Texas
- University of Texas MD Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 491 participants |
| Start Date | 2008-05-09 |
| Est. Completion | 2019-01-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00688168
The ClinicalTrials.gov registry entry for NCT00688168 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 491 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 546-participant average among 438 other Multiple Myeloma trials with a reported enrollment target (10% lower). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Multiple Myeloma appearing as the primary indexed condition, and to 3 interventions - of which Questionnaire is the first listed.
NCT00688168 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT00688168 about?
NCT00688168 is a clinical study titled "Inflammatory Cytokines in Symptom Production in Multiple Myeloma". The goal of this research study is to learn about the pain and/or other symptoms that patients may experience either while you are being monitored by your doctor before a decision is made to start you on treatment for your MM, or during and after treatment for MM, and how these symptoms may affect t...
What is the current status of trial NCT00688168?
This trial is currently completed. The enrollment target is 491 participants. The study started on 2008-05-09. Estimated completion is 2019-01-08.
What conditions does trial NCT00688168 study?
This clinical trial studies the following conditions: Multiple Myeloma.
What interventions are being tested in trial NCT00688168?
The interventions under investigation include: Questionnaire (BEHAVIORAL), Neurocognitive Testing (BEHAVIORAL), Neurosensory Testing (BEHAVIORAL).
Who is sponsoring clinical trial NCT00688168?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00688168 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Multiple Myeloma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
A Study of Whether Ide-cel (bb2121) Can Be Made From People With Multiple Myeloma Who Have Had a Hematopoietic Cell Transplant
RECRUITING · Phase 2
-
A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments
RECRUITING · Phase 1
-
A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)
RECRUITING · NA
-
Development of a Research Infrastructure for Understanding and Addressing Multiple Myeloma Disparities
RECRUITING
-
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
RECRUITING
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.